Physician profile
Anna Torres
NPI 1346295474
$6,547.95
in general payments reported to CMS, 2019-2025
22 companies · $591 in 2025
The $591 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $870 · 2020: $475 · 2021: $839 · 2022: $1,663 · 2023: $1,246 · 2024: $864 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,576 · Entertainment: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,576.15 |
| Entertainment | $124.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,322.74 | 2019-2025 | Myday Contact Lens, Ortho-K Contact Lens, Misight Contact Lens |
| Sight Sciences, INC. | $839.34 | 2021-2024 | Tearcare System |
| Alcon Vision LLC | $690.55 | 2019-2025 | Dailies Total1, Dailies, Precision7 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $610.58 | 2019-2021 | |
| Lkc Technologies, INC. | $427.12 | 2023-2024 | |
| Bausch & Lomb Americas INC. | $403.19 | 2022-2024 | Infuse |
| Optos, INC. | $385.15 | 2019-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Vision Care, INC. | $285.16 | 2019-2025 | |
| Kala Pharmaceuticals, INC. | $218.96 | 2021-2022 | |
| Glaukos Corporation | $195.07 | 2022 | |
| Topcon Healthcare, INC. | $193.36 | 2020 | |
| Visioneering Technologies, INC. | $159.95 | 2019-2023 | |
| Biotissue Holdings INC. | $150.27 | 2024 | |
| Visionary Optics LLC | $146.71 | 2023 | |
| Sun Pharmaceutical Industries INC. | $124.97 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $121.34 | 2021-2022 | |
| Oyster Point Pharma, INC. | $82.66 | 2023-2025 | Tyrvaya |
| Lombart Brothers, INC. | $60.38 | 2025 | Opd-III |
| Rxsight INC | $49.60 | 2025 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Abb Con-Cise Optical Group LLC | $41.00 | 2019 | |
| Shire North American Group INC | $22.61 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.